Multimodal single-cell analyses reveal distinct fusion-regulated transcriptional programs in Ewing sarcoma
Ewing sarcoma (EwS) is a fusion-driven malignancy, peaking in adolescence. Although EwS tumors are driven uniquely by EWS::FLI1 and related fusions, patient outcomes vary greatly. If and how tumor plasticity of EWS::FLI1-regulated transcriptional signatures contributes to disease progression is not known. To address this, we utilized a single-cell co-assay of RNA and chromatin accessibility…
Ewing sarcoma, a cancer type driven by specific genetic fusions, typically affects young patients. While tumors arising from these fusions tend to share certain characteristics, individual patient responses to the disease can differ significantly. The extent to which this variability in patient outcomes might be attributable to changes in the molecular profile of the tumors remains unclear.
To shed light on this issue, researchers employed an advanced analytical technique - single-cell co-assay of RNA and chromatin accessibility sequencing. This method allowed them to simultaneously examine both the gene expression patterns and the accessibility of DNA, thus uncovering intricate regulatory networks at play within Ewing sarcoma cells.
By scrutinizing these regulatory networks across a variety of cell lines, the scientists were able to identify several distinct clusters of genes that share common regulatory mechanisms. These clusters, or modules, displayed varying degrees of usage and prevalence among different cell lines. Furthermore, their presence was linked to unique epigenetic and transcriptomic characteristics, and in some instances, the activity of these modules could be influenced by external factors such as TGF-β.
When the researchers turned their attention to actual Ewing sarcoma tumors obtained from patients, they noticed that these same regulatory modules exhibited varying degrees of enrichment not only across but also within individual tumors. This observation underscores the presence of intratumoral heterogeneity, or diversity within the tumor, in terms of gene regulatory networks.
The study's findings imply that numerous, concurrent transcriptional programs may collectively contribute to the phenotypic diversity observed in Ewing sarcoma. This diversity could potentially have significant implications for the clinical course of the disease and the development of targeted therapies.
Rewritten by urgent.news; may contain errors — check the original.
Source: elifesciences.org